JPS6136491B2 - - Google Patents
Info
- Publication number
- JPS6136491B2 JPS6136491B2 JP53073792A JP7379278A JPS6136491B2 JP S6136491 B2 JPS6136491 B2 JP S6136491B2 JP 53073792 A JP53073792 A JP 53073792A JP 7379278 A JP7379278 A JP 7379278A JP S6136491 B2 JPS6136491 B2 JP S6136491B2
- Authority
- JP
- Japan
- Prior art keywords
- nitroglycerin
- patch
- angina
- weight
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- SNIOPGDIGTZGOP-UHFFFAOYSA-N Nitroglycerin Chemical compound [O-][N+](=O)OCC(O[N+]([O-])=O)CO[N+]([O-])=O SNIOPGDIGTZGOP-UHFFFAOYSA-N 0.000 claims description 49
- 239000000006 Nitroglycerin Substances 0.000 claims description 48
- 229960003711 glyceryl trinitrate Drugs 0.000 claims description 48
- 239000008194 pharmaceutical composition Substances 0.000 claims description 13
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 8
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 claims description 6
- 229960000846 camphor Drugs 0.000 claims description 6
- 241000723346 Cinnamomum camphora Species 0.000 claims description 5
- 108010010803 Gelatin Proteins 0.000 claims description 5
- 229930008380 camphor Natural products 0.000 claims description 5
- 229920000159 gelatin Polymers 0.000 claims description 5
- 239000008273 gelatin Substances 0.000 claims description 5
- 235000019322 gelatine Nutrition 0.000 claims description 5
- 235000011852 gelatine desserts Nutrition 0.000 claims description 5
- 235000011187 glycerol Nutrition 0.000 claims description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 4
- GUBGYTABKSRVRQ-QKKXKWKRSA-N lactose group Chemical group OC1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@@H](O)[C@H](O2)CO)[C@H](O1)CO GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 3
- 239000008101 lactose Substances 0.000 claims description 2
- 150000001720 carbohydrates Chemical class 0.000 claims 1
- 206010002383 Angina Pectoris Diseases 0.000 description 27
- 238000004519 manufacturing process Methods 0.000 description 19
- 230000000694 effects Effects 0.000 description 9
- 230000017531 blood circulation Effects 0.000 description 8
- 230000000052 comparative effect Effects 0.000 description 7
- 230000000699 topical effect Effects 0.000 description 7
- 238000000034 method Methods 0.000 description 6
- 229920003002 synthetic resin Polymers 0.000 description 6
- 239000000057 synthetic resin Substances 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 238000010521 absorption reaction Methods 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 239000006190 sub-lingual tablet Substances 0.000 description 5
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 4
- 229910052782 aluminium Inorganic materials 0.000 description 4
- 239000011248 coating agent Substances 0.000 description 4
- 238000000576 coating method Methods 0.000 description 4
- 239000011888 foil Substances 0.000 description 4
- -1 Softeners Substances 0.000 description 3
- 230000003247 decreasing effect Effects 0.000 description 3
- 239000002075 main ingredient Substances 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 235000000346 sugar Nutrition 0.000 description 3
- 206010010904 Convulsion Diseases 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- 206010040880 Skin irritation Diseases 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- 230000001070 adhesive effect Effects 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 210000004351 coronary vessel Anatomy 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 239000003607 modifier Substances 0.000 description 2
- 210000004400 mucous membrane Anatomy 0.000 description 2
- 230000002107 myocardial effect Effects 0.000 description 2
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 238000004806 packaging method and process Methods 0.000 description 2
- 239000000123 paper Substances 0.000 description 2
- 230000036470 plasma concentration Effects 0.000 description 2
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 2
- 229920000053 polysorbate 80 Polymers 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- 230000001953 sensory effect Effects 0.000 description 2
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 description 2
- 230000036556 skin irritation Effects 0.000 description 2
- 231100000475 skin irritation Toxicity 0.000 description 2
- 229940098466 sublingual tablet Drugs 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- WOEPIQOANYGRGK-RJMJUYIDSA-N (2R,3R,4S,5R,6S)-2-(hydroxymethyl)-6-[(2R,3S,4R,5R)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxane-3,4,5-triol propane-1,2,3-triol Chemical compound OCC(O)CO.O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O WOEPIQOANYGRGK-RJMJUYIDSA-N 0.000 description 1
- DMBSFYPSHNCYAR-RJMJUYIDSA-N 1,3-dinitrooxypropan-2-yl nitrate (2R,3R,4S,5R,6S)-2-(hydroxymethyl)-6-[(2R,3S,4R,5R)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxane-3,4,5-triol Chemical compound [O-][N+](=O)OCC(O[N+]([O-])=O)CO[N+]([O-])=O.O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O DMBSFYPSHNCYAR-RJMJUYIDSA-N 0.000 description 1
- 208000019300 CLIPPERS Diseases 0.000 description 1
- 241000282465 Canis Species 0.000 description 1
- 229920000298 Cellophane Polymers 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 241000700157 Rattus norvegicus Species 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 239000000043 antiallergic agent Substances 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 208000021930 chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids Diseases 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 239000003218 coronary vasodilator agent Substances 0.000 description 1
- 239000003405 delayed action preparation Substances 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000352 effect on angina Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000013022 formulation composition Substances 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 229960000201 isosorbide dinitrate Drugs 0.000 description 1
- MOYKHGMNXAOIAT-JGWLITMVSA-N isosorbide dinitrate Chemical compound [O-][N+](=O)O[C@H]1CO[C@@H]2[C@H](O[N+](=O)[O-])CO[C@@H]21 MOYKHGMNXAOIAT-JGWLITMVSA-N 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 230000000422 nocturnal effect Effects 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 239000011088 parchment paper Substances 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000011505 plaster Substances 0.000 description 1
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 239000004800 polyvinyl chloride Substances 0.000 description 1
- 229920000915 polyvinyl chloride Polymers 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 229910001961 silver nitrate Inorganic materials 0.000 description 1
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000003206 sterilizing agent Substances 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 238000013268 sustained release Methods 0.000 description 1
- 239000012730 sustained-release form Substances 0.000 description 1
- 229920001169 thermoplastic Polymers 0.000 description 1
- 239000004416 thermosoftening plastic Substances 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP7379278A JPS552604A (en) | 1978-06-20 | 1978-06-20 | Patch agent consisting mainly of nitroglycerin |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP7379278A JPS552604A (en) | 1978-06-20 | 1978-06-20 | Patch agent consisting mainly of nitroglycerin |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS552604A JPS552604A (en) | 1980-01-10 |
JPS6136491B2 true JPS6136491B2 (fr) | 1986-08-19 |
Family
ID=13528384
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP7379278A Granted JPS552604A (en) | 1978-06-20 | 1978-06-20 | Patch agent consisting mainly of nitroglycerin |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS552604A (fr) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1163561A (fr) * | 1979-11-06 | 1984-03-13 | Cyril Boroda | Preparation contenant de la nitroglycerine et parfois d'autres medicaments et methode de preparation |
JPS56123912A (en) * | 1980-03-05 | 1981-09-29 | Nitto Electric Ind Co Ltd | Drug-containing tape preparation |
JPS56133381A (en) * | 1980-03-25 | 1981-10-19 | Nippon Kayaku Co Ltd | Pressure-sensitive adhesive tape or sheet containing nitroglycerin |
JPH03246219A (ja) * | 1980-03-25 | 1991-11-01 | Nippon Kayaku Co Ltd | ニトログリセリンを含有する感圧性粘着テープまたはシート |
JPS577412A (en) * | 1980-06-14 | 1982-01-14 | Nitto Electric Ind Co Ltd | Plaster |
JPS5777617A (en) * | 1980-10-20 | 1982-05-15 | Nichiban Co Ltd | Plaster for cardiac disease |
JPS5843368B2 (ja) * | 1980-10-30 | 1983-09-27 | 日東電工株式会社 | 消炎鎮痛貼付剤 |
JPS57116011A (en) * | 1981-01-08 | 1982-07-19 | Nitto Electric Ind Co Ltd | Pharmaceutical preparation |
JPS57183714A (en) * | 1981-05-01 | 1982-11-12 | Nitto Electric Ind Co Ltd | Medicinal pharmaceutical |
JPS61251618A (ja) * | 1985-04-30 | 1986-11-08 | Nitto Electric Ind Co Ltd | 外用医薬部材 |
JPH0696529B2 (ja) * | 1987-03-31 | 1994-11-30 | 積水化学工業株式会社 | ニトログリセリン貼付剤およびその製造方法 |
JPS63246326A (ja) * | 1987-11-07 | 1988-10-13 | Nippon Kayaku Co Ltd | ニトログリセリンを含有する感圧性粘着テープまたはシートの製造方法 |
JPH07116032B2 (ja) * | 1990-04-06 | 1995-12-13 | 積水化学工業株式会社 | ニトログリセリン貼付剤 |
DE19701949A1 (de) * | 1997-01-13 | 1998-07-16 | Jenapharm Gmbh | Transdermales therapeutisches System |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS4858117A (fr) * | 1971-11-22 | 1973-08-15 | ||
JPS4950127A (fr) * | 1972-09-22 | 1974-05-15 | ||
JPS52143223A (en) * | 1976-05-25 | 1977-11-29 | Watanabe Yakuhin Kogyo Kk | Pap gent |
JPS5350320A (en) * | 1976-10-14 | 1978-05-08 | Watanabe Yakuhin Kogyo Kk | Hydrophylic plaster |
-
1978
- 1978-06-20 JP JP7379278A patent/JPS552604A/ja active Granted
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS4858117A (fr) * | 1971-11-22 | 1973-08-15 | ||
JPS4950127A (fr) * | 1972-09-22 | 1974-05-15 | ||
JPS52143223A (en) * | 1976-05-25 | 1977-11-29 | Watanabe Yakuhin Kogyo Kk | Pap gent |
JPS5350320A (en) * | 1976-10-14 | 1978-05-08 | Watanabe Yakuhin Kogyo Kk | Hydrophylic plaster |
Also Published As
Publication number | Publication date |
---|---|
JPS552604A (en) | 1980-01-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4486193A (en) | Method for treating ischemic conditions by administering drug by two routes | |
US4704119A (en) | Method comprising transdermal and buccal treatment of angina | |
US4650484A (en) | Method for treating ischemic conditions | |
Dixit et al. | Oral strip technology: Overview and future potential | |
JPS6136491B2 (fr) | ||
KR100267359B1 (ko) | 항혈전성 치료 및 암 예방을 위한 아세틸살리실산을 함유하는 경피 투여 시스템 | |
US4696821A (en) | Transdermal delivery system for administration of nitroglycerin | |
FR2567758A1 (fr) | Compositions therapeutiques a base de ginkgolides pour le traitement ou la prevention des maladies provoquees par l'acether du facteur d'activation des plaquettes (paf-acether) | |
JPH09504810A (ja) | 水溶性感圧粘膜接着剤 | |
WO2005123024A1 (fr) | Produits pour le blanchiment des dents et leurs procedes de fabrication | |
JPH0541602B2 (fr) | ||
JP2000512996A (ja) | 皮膚感作および刺激の予防および治療措置 | |
JPS58213709A (ja) | 歯肉粘膜用貼付剤 | |
KR20170139979A (ko) | 신장성을 갖는 구강용 실링랩 | |
Jaiswal | Oral strip technology: A review | |
JP2001512428A (ja) | 伸長性のある経皮治療システム | |
WO2006042928A1 (fr) | Composition pour prevenir ou traiter le stress, notamment les bouffees de stress chronique et permanent | |
JPH01230514A (ja) | エアゾール型外用貼付剤 | |
JP2007512270A (ja) | デオキシペガニンの経口製剤およびそれらの使用 | |
JP3799502B2 (ja) | 抗血栓治療および癌予防のためのアセチルサリチル酸を含有する経皮投与システム | |
JP2001505222A (ja) | 生物体にペプチド系医薬を導入するための局所用製剤 | |
JPH0335285B2 (fr) | ||
Bhatt et al. | A review on buccal mucosal route of drug administration | |
JPS60214732A (ja) | 外用貼付剤 | |
JPS6317809B2 (fr) |